Compare ADCT & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADCT | ULH |
|---|---|---|
| Founded | 2011 | 1932 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 484.4M | 462.1M |
| IPO Year | 2019 | 2004 |
| Metric | ADCT | ULH |
|---|---|---|
| Price | $4.14 | $14.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $7.50 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 903.2K | 32.5K |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | 30.86 | ★ 39.66 |
| EPS | ★ N/A | N/A |
| Revenue | $81,357,000.00 | ★ $1,461,708,000.00 |
| Revenue This Year | $1.15 | N/A |
| Revenue Next Year | $86.93 | $3.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 14.85 | N/A |
| 52 Week Low | $1.05 | $12.78 |
| 52 Week High | $4.98 | $30.76 |
| Indicator | ADCT | ULH |
|---|---|---|
| Relative Strength Index (RSI) | 48.68 | 40.49 |
| Support Level | $3.79 | $12.78 |
| Resistance Level | $4.63 | $18.79 |
| Average True Range (ATR) | 0.31 | 1.28 |
| MACD | 0.00 | -0.27 |
| Stochastic Oscillator | 17.79 | 23.63 |
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.